由于盖子不安全, 沃尔玛和特价公司将召回5万瓶的马米桑止痛药. A recall affects 50,000 Mamisan pain ointment jars sold at Walmart and Target due to non-child-resistant lids.

由于包装不具儿童抗性，沃尔玛和Target于2024年4月至2025年10月期间销售的Mamisan止痛外用软膏已被全国召回。 A nationwide recall has been issued for Mamisan Pain Relieving Topical Ointment sold at Walmart and Target from April 2024 through October 2025 due to its non-child-resistant packaging. 该产品含有利多卡因,如果被儿童吞咽,将构成严重风险。 The product, containing lidocaine, poses a serious risk if swallowed by children. 只有带有UPC 860006498115的罐子——亮橙色，白色旋盖——才会受到影响。 Only jars with UPC 860006498115—bright orange with a white twist-off lid—are affected. 美国消费者产品安全委员会正在监督召回,敦促消费者与Plantimex联系,以获得免费更换盖子。 The U.S. Consumer Product Safety Commission is overseeing the recall, and consumers are urged to contact Plantimex for a free replacement lid. 约50 000个单位被召回。 The recall affects about 50,000 units.